2-[4-(aminomethyl)piperidin-1-yl]-n-tert-butylacetamide, 95%, 2g

(S)-4-N-Boc-Piperazine-2-carboxylic acid methyl ester, 97.0%, 10g

(1-methyl-3-(pyridin-4-yl)-1H-pyrazol-4-yl)methanamine, 95.0%, 250mg

2,2,3,4,4,4-Hexafluorobutyl Methacrylate (stabilized with MEHQ)>98.0%(GC)25g

(R)-1-(tert-Butoxycarbonyl)-2,5-dihydro-1H-pyrrole-2-carboxylic acid, 95%, 1g

N-(4-aminophenyl)-2,3-dihydro-1,4-benzodioxine-6-sulfonamide, 100mg

Vinyl terminated polydimethylsiloxane cSt 100,000, 100g

Potassium iodide, min. 99.5%, pa, ISO, 250 g, glass packaging

8-(Trifluoromethyl)-2-azaspiro[4.5]decane, 95%, 100mg

1-(4-Methoxyphenyl)-3-oxocyclobutane-1-carboxylic acid, 95+%, 5g

3-Chloro-4-fluorobenzoic Acid>98.0%(GC)(T)25g

Embedding cassettes, white 500 pcs

(1s,3s)-1-(4-Chlorophenyl)-3-hydroxycyclobutanecarboxylic acid, 97%, 250mg